跳转至内容
Merck
所有图片(1)

主要文件

K1140

Sigma-Aldrich

Kifunensine

solid,film or powder, ≥98%

别名:

FR 900494, 六氢6R,7S,8aS-三羟基-5R-(羟甲基)-咪唑并[1,2-a]吡啶-2,3-二酮

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C8H12N2O6
分子量:
232.19
分類程式碼代碼:
12352204
NACRES:
NA.77

product name

Kifunensine, mannosidase inhibitor

生物源

synthetic (organic)

品質等級

化驗

≥98%

形狀

film or powder
solid

溶解度

water, double-distilled: 50 mM

儲存溫度

−20°C

InChI

1S/C8H12N2O6/c11-1-2-3(12)4(13)5(14)6-9-7(15)8(16)10(2)6/h2-6,11-14H,1H2,(H,9,15)/t2-,3-,4+,5+,6+/m1/s1

InChI 密鑰

OIURYJWYVIAOCW-PQMKYFCFSA-N

一般說明

Kifunensine是一种生物碱化合物,从放线菌Kitasporia kifunensis中分离出来。

應用

Kifunensine已用作Jurkat T细胞、人胚胎肾脏(HEK293T / 17)细胞和小鼠胚胎成纤维细胞中的甘露糖苷酶I抑制剂。

生化/生理作用

Kifunensine是一类糖蛋白加工甘露糖苷酶的选择性抑制剂。
Kifunensine通过抑制内质网相关的甘露糖苷酶的活性来抑制内质网相关的降解(ERAD)。它也是I类CAZy糖基水解酶家族47的糖苷酶抑制剂。

象形圖

Exclamation mark

訊號詞

Warning

危險聲明

危險分類

Eye Irrit. 2

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable

個人防護裝備

Eyeshields, Gloves, type N95 (US)


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

A D Elbein et al.
The Journal of biological chemistry, 265(26), 15599-15605 (1990-09-15)
Kifunensine, produced by the actinomycete Kitasatosporia kifunense 9482, is an alkaloid that corresponds to a cyclic oxamide derivative of 1-amino mannojirimycin. This compound was reported to be a weak inhibitor of jack bean alpha-mannosidase (IC50 of 1.2 x 10(-4) M)
N-glycosylation of asparagine 8 regulates surface expression of major histocompatibility complex class I chain-related protein A (MICA) alleles dependent on threonine 24
Mellergaard M, et al.
The Journal of Biological Chemistry, 289(29), 20078-20091 (2014)
Christopher N Scanlan et al.
Journal of molecular biology, 372(1), 16-22 (2007-07-17)
The HIV envelope has evolved a dense array of immunologically "self" carbohydrates that efficiently protect the virus from antibody recognition. Nonetheless, one broadly neutralising antibody, IgG1 2G12, has been shown to recognise a cluster of oligomannose glycans on the HIV-1
Andrew I Flyak et al.
eLife, 9 (2020-03-04)
A vaccine protective against diverse HCV variants is needed to control the HCV epidemic. Structures of E2 complexes with front layer-specific broadly neutralizing antibodies (bNAbs) isolated from HCV-infected individuals, revealed a disulfide bond-containing CDRH3 that adopts straight (individuals who clear
Qun Zhou et al.
Biotechnology and bioengineering, 99(3), 652-665 (2007-08-08)
Glycosylation in the Fc region of antibodies has been shown to play an important role in antibody function. In the current study, glycosylation of human monoclonal antibodies was metabolically modulated using a potent alpha-mannosidase I inhibitor, kifunensine, resulting in the

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门